Blend Labs, Inc.
NYSE:BLNDSoftware - Application
-$0.03 today
- Market cap
- $218.02M
- Beta
- 1.09
- P/E (TTM)
- -71.2
- EPS (TTM)
- -$0.02
Volume 1.19M
Average 3.92M
BLND Accounts Receivables
Cash effect of the change in amounts owed by customers; growing receivables consume cash.
Blend Labs, Inc.NYSE: BLND
Accounts Receivables · Q1 FY2026 · quarter ended Mar 2026
Accounts receivables turns negative
Q1 FY2026 accounts receivables was -$9.06M, compared with $3.91M a year earlier. Trailing-twelve-month accounts receivables was -$7.21M. Over 3 fiscal years it compounded at -22.3% a year.
Context
- Accounts receivables amounted to 4.7% of revenue in FY2025, up 4.1 pp from a year earlier.
- Accounts receivables increased in 1 of the last 3 fiscal years.
What to watch
Whether quarterly accounts receivables holds near -$9.06M or moves back toward the trailing-twelve-month quarterly average of -$1.8M.
Sources:Cash FlowText generated from reported figures; not investment advice.
Accounts Receivables history
USD · from the cash flow
- Latest · FY2025
- 5.76M USD
- Year-over-year change
- +527.5%
| Period | Period end | Accounts Receivables | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 5.76M | +527.5% |
| FY2024 | 2024-12-31 | 918K | -78.5% |
| FY2023 | 2023-12-31 | 4.27M | -65.2% |
| FY2022 | 2022-12-31 | 12.29M | +310.5% |
| FY2021 | 2021-12-31 | (5.84M) | — |
Accounts Receivables vs competitors
How BLND compares with its peers on the latest reported figures
- BLND's LTM Mar 2026 accounts receivables of $7.21M is the 5th largest of the 10 companies compared; the peer median is $688K.
- Its year-over-year change of -188.8% is the 9th highest of 10, against a peer median of +149.3%.
- Accounts receivables amounts to 5.6% of revenue for BLND, versus a peer median of 3.3%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $70.19M | +396.3% | +43.8% | 12.4% | |
| LTM Mar 2026 | $33.29M | -183.0% | -18.4% | 3.0% | |
| LTM Mar 2026 | $20.79M | +1808.4% | — | 6.1% | |
| LTM Mar 2026 | $8.16M | +149.3% | — | 3.3% | |
| LTM Mar 2026 | $7.21M | -188.8% | -22.3% | 5.6% | |
| LTM Mar 2026 | $3.53M | +161.1% | -3.6% | 1.4% | |
| LTM Mar 2026 | $3.5M | -433.4% | -7.4% | 1.0% | |
| LTM Mar 2026 | $3.11M | +47.5% | +19.8% | 3.3% | |
| LTM Mar 2026 | $1.45M | +216.9% | — | 0.2% | |
LAESSEALSQ Corp | FY2025 | $688K | -52.6% | +21.1% | 3.8% |
| Peer median (excluding BLND) | $688K | +149.3% | +8.1% | 3.3% | |
Competitors are the stored peer set for BLND. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | (169.14M) | (763.81M) | (179.88M) | (43.42M) | (25.97M) |
| Depreciation & Amortization | 13.81M | 14.42M | 5.76M | 4.82M | 3.82M |
| Deferred Income Tax | (39.31M) | 0 | 0 | 0 | 0 |
| Stock-Based Compensation | 70.84M | 109.7M | 46.02M | 28.08M | 28.96M |
| Change in Working Capital | (13.07M) | (4.48M) | (4.25M) | 1.89M | (2.73M) |
| Accounts Receivables | (5.84M) | 12.29M | 4.27M | 918K | 5.76M |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Accounts Payables | 1.56M | (4.9M) | 910K | (67K) | 206K |
| Other Working Capital | (8.79M) | (11.87M) | (9.44M) | 1.04M | (8.7M) |
| Other Non-Cash Items | 9.36M | 453.76M | 4.73M | (4.41M) | 7.43M |
| Operating Cash Flow | (127.5M) | (190.42M) | (127.62M) | (13.04M) | 11.51M |
| Capital Expenditures | (1.89M) | (2.07M) | (587K) | (9.84M) | (11.59M) |
| Acquisitions (Net) | (400.01M) | 0 | 0 | 9.08M | 0 |
| Purchases of Investments | (354.08M) | (145.54M) | (236.08M) | (102.03M) | (35.49M) |
| Sales of Investments | 125.08M | 247.04M | 366.47M | 153.48M | 46.73M |
| Other Investing Activities | (3M) | 0 | (2.5M) | (5.28M) | 18.89M |
| Investing Cash Flow | (633.91M) | 99.43M | 127.31M | 45.4M | 18.54M |
| Debt Repayment | 221.67M | 0 | (85.06M) | (144.5M) | 0 |
| Common Stock Issued | 366.81M | 0 | 268K | 0 | 1.65M |
| Common Stock Repurchased | 0 | (391K) | 0 | 0 | (24.87M) |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 35.39M | 2.61M | (6.17M) | (25.94M) | (9.37M) |
| Financing Cash Flow | 933.57M | 2.22M | (90.96M) | (21.06M) | (32.59M) |
| Effect of Forex Changes | (9K) | (116K) | (31K) | (5K) | (1.15M) |
| Net Change in Cash | 172.15M | (88.88M) | (91.3M) | 11.28M | (3.69M) |
| Free Cash Flow | (129.39M) | (192.49M) | (128.21M) | (22.89M) | (81K) |
Blend Labs, Inc.
NYSE:BLND
Intrinsic Alpha fair value
Locked
Current Price
$0.93
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.